StockData
Hyperfine, Inc. logo

Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.54−0.02 (-2.97%)

Close on Nov 18, 2026Market cap $57.79MP/E –Yield –

Hyperfine revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Hyperfine's revenue for the twelve months ending Jun 30, 2026 was $16.54M, up 53.2% year over year. For fiscal 2025 it was $13.56M, up 5.2% from the year before. The highest annual figure on record is $13.56M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.56M+5.2%
FY2024Dec 31, 2024$12.89M+16.8%
FY2023Dec 31, 2023$11.03M+61.9%
FY2022Dec 31, 2022$6.81M+355.5%
FY2021Dec 31, 2021$1.50M+408.8%
FY2020Dec 31, 2020$294.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.90M+44.8%
Q1 FY2026Mar 31, 2026$3.90M+82.6%
Q4 FY2025Dec 31, 2025$5.29M+128.0%
Q3 FY2025Sep 30, 2025$3.44M-5.7%
Q2 FY2025Jun 30, 2025$2.70M-25.8%
Q1 FY2025Mar 31, 2025$2.14M-35.1%
Q4 FY2024Dec 31, 2024$2.32M-13.6%
Q3 FY2024Sep 30, 2024$3.64M+56.4%
Q2 FY2024Jun 30, 2024$3.63M+7.4%
Q1 FY2024Mar 31, 2024$3.30M+25.0%
Q4 FY2023Dec 31, 2023$2.69M+88.6%
Q3 FY2023Sep 30, 2023$2.33M-0.8%
Q2 FY2023Jun 30, 2023$3.38M+120.5%
Q1 FY2023Mar 31, 2023$2.64M+74.6%
Q4 FY2022Dec 31, 2022$1.42M+226.6%
Q3 FY2022Sep 30, 2022$2.35M+532.9%
Q2 FY2022Jun 30, 2022$1.53M+328.2%
Q1 FY2022Mar 31, 2022$1.51M+355.9%
Q4 FY2021Dec 31, 2021$436.00K–
Q3 FY2021Sep 30, 2021$371.00K–
Q2 FY2021Jun 30, 2021$358.00K–
Q1 FY2021Mar 31, 2021$331.00K–

More Hyperfine figures

See a number that looks wrong?